Clinical trial of imatinib (Gleevec) in ovarian cancer | Download Table
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease | Leukemia
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia | NEJM
GLIVEC® (imatinib) in Newly Metastatic KIT+ GIST
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials | Haematologica
Gastrointestinal Stromal Tumors: Management of Advanced Disease | MDedge Hematology and Oncology
Effect of imatinib alone or in combination in melanoma clinical trials. | Download Scientific Diagram
Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study | Leukemia
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment - Clinical Lymphoma, Myeloma and Leukemia
Imatinib resistance: a role for dasatinib
Imatinib (Gleevec™)
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia | NEJM
Summary of clinical trials where imatinib mesylate (Gleevec, Novartis)... | Download Table
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia - Clinical Therapeutics
GLEEVEC® (imatinib mesylate) | KIT + GIST & Ph+ CML
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia | NEJM
Phase II Clinical Trial of Imatinib Mesylate in Therapy of KIT and/or PDGFRα-expressing Ewing Sarcoma Family of Tumors and Desmoplastic Small Round Cell Tumors | Anticancer Research
Kinase drug discovery 20 years after imatinib: progress and future directions | Nature Reviews Drug Discovery
Phase III clinical trials of adjuvant imatinib therapy. | Download Table
Summary of selected randomized clinical trials evaluating high-dose... | Download Table
